Key Stakeholders Needed in the Development of Outpatient Naloxone Policies

Article
Conference|PAINWeek Conference

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.

Related Videos
Related Content
woman holding hands near head while suffering from headache in bedroom | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com

Migraine Treatment Comes in Different Forms, Allowing for Patient Preference

April 23rd 2024
Article
Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

April 5th 2024
Podcast
Microglia are immune cells in the brain | Image Credit: Artur - stock.adobe.com

Study: Frexalimab Shows Sustained Reduction of Disease Activity for Multiple Sclerosis

April 23rd 2024
Article
Pharmacy Focus: OTC Contraception and Reproductive Health

Pharmacy Focus: OTC Contraception and Reproductive Health

March 29th 2024
Podcast
Health and medicine - Young girl using blue asthma inhaler to prevent an asthma attack. - Image credit: DALU11 | stock.adobe.com

Condition Watch: Asthma

April 23rd 2024
Article
Clinic. Doctor Makes Blood. Test. Have Fun. Belly. - Image credit: VadimGuzhva | stock.adobe.com

SGLT2 Inhibitors Show Considerable Efficacy for Diabetes Management

April 23rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.